Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

December 26, 2023

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
BIOLOGICAL

Tislelizumab

Tislelizumab is a monoclonal antibody formulated for intravenous injection.

BIOLOGICAL

Ociperlimab

Ociperlimab is a monoclonal antibody formulated for intravenous injection.

DRUG

Placebo

Ociperlimab placebo injection is a sterile, preservative-free solution for infusion formulated in the same buffer as ociperlimab active drug.

Trial Locations (86)

75015

Hopital Europeen Georges Pompidou - Digestive Oncology, Paris

80621

CHU de Poitiers, Poitiers

140100

Shanxi Provincial People's Hospital, Taiyuan

226000

Nantong Tumor Hospital, Nantong

230088

Anhui Provincial Cancer Hospital, Hefei

250117

Shandong Cancer Hospital, Jinan

361003

First Affiliated Hospital of Xiamen University, Xiamen

362002

Quanzhou First Hospital of Fujian Province, Quanzhou

Unknown

Lanzhou University Second Hospital, Gansu

Guangdong Provincial Hospital of Chinese Medicine, Guangzhou

Meizhou Hospital Affiliated to Sun Yat-sen University, Guangzhou

Hainan Third People's Hospital, Sanya

Affiliated Hospital of Jiangnan University, Wuxi

General Hospital of Ningxia Medical University, Yinchuan

Qinghai Provincial People's Hospital, Qinghai

People's Hospital of Deyang City, Deyang

Tianjin Medical University Cancer Institute & Hospital, Tianjin

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Yunnan Cancer Hospital, Kunming

First Affiliated Hospital of Kunming Medical University, Yunnan

Beijing Cancer Hospital, Beijing

Beijing Friendship Hospital, Capital Medical University, Beijing

The First People's Hospital of Changzhou, Changzhou

Fujian Cancer Hospital, Fujian

The First Affiliated Hospital of Fujian Medical University, Fujian

Zhongshan Hospital Xiamen University, Fujian

Cancer Hospital of Shantou University Medical College, Guangdong

Nanfang Hospital of Southern Medical University, Guangdong

Sun Yat-sen University Cancer Center, Guangdong

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong

Guangxi Medical University Affiliated Tumor Hospital, Guangxi

Hainan General Hospital, Hainan

Affiliated Hospital of Hebei University, Hebei

The Second Hospital of Anhui Medical University, Hefei

Harbin Medical University Cancer Hospital, Heilongjiang

Henan Cancer Hospital, Henan

The First Affiliated Hospital of Xinxiang Medical University, Henan

The First Affiliated Hospital of Zhengzhou University, Henan

Hubei Cancer Hospital, Hubei

Xiangyang Central Hospital, Hubei

Hunan Cancer Hospital, Hunan

The First Affiliated Hospital of Nanchang University, Jiangxi

The Second Affiliated Hospital of Nanchang University, Jiangxi

Linyi Cancer Hospital, Shandong

Weifang People's Hospital, Shandong

Shanghai Chest Hospital, Shanghai

Liaoning Cancer Hospital & Institute, Shenyang

Sichuan Provincial People's Hospital, Sichuan

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

Northern Jiangsu People's Hospital, Yangzhou

Hangzhou Cancer Hospital, Zhejiang

Hwa Mei Hospital, University of Chinese Academy of Sciences, Zhejiang

Centre Hospitalier Universitaire d'Amiens - Hopital Sud, Amiens

Hôpital de la Timone, Marseille

Ajou University Hospital, Gyeonggi-do

Chonnam National University Hwasun Hospital, Jeongnam

Asan Medical Center, Seoul

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Yonsei University Health System, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

Hospital Clínic de Barcelona, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Institut Catala D'Oncologia, L'Hospitalet de Llobregat

Hospital Universitario Madrid Sanchinarro, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Regional Universitario de Málaga, Málaga

Hospital Universitario Marqués de Valdecilla, Santander

Hospital Clinico Universitario de Valencia - Incliva, Valencia

Hospital Universitario Miguel Servet, Zaragoza

Chiayi Chang Gung Memorial Hospital, Chiayi City

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

China Medical University Hospital, Taichung

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Linkou Chang Gung Memorial Hospital, Taoyuan District

Chulabhorn Hospital, Bangkok

Phramongkutklao Hospital, Bangkok

Rajavithi Hospital, Bangkok

Siriraj Hospital, Bangkok

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, Chiang Mai

Songklanagarind Hospital, Prince of Songkla University, Hat Yai

046000

Heping Hospital Affiliated to Changzhi Medical College, Changzhi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY